112 related articles for article (PubMed ID: 1901830)
21. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
22. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
23. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
Sabapathy TK; Cheng Q; Hui KM
Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974
[TBL] [Abstract][Full Text] [Related]
24. Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules.
Baskar S; Clements VK; Glimcher LH; Nabavi N; Ostrand-Rosenberg S
J Immunol; 1996 May; 156(10):3821-7. PubMed ID: 8621919
[TBL] [Abstract][Full Text] [Related]
25. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
[TBL] [Abstract][Full Text] [Related]
26. Induction and maintenance of T-cell response to a nonimmunogenic murine mesothelioma cell line requires expression of B7-1 and the capacity to upregulate class II major histocompatibility complex expression.
Leong C; Marley J; Loh S; Robinson B; Garlepp M
Cancer Gene Ther; 1996; 3(5):321-30. PubMed ID: 8894251
[TBL] [Abstract][Full Text] [Related]
27. Serological analysis of H-2 antigens expression on the cell surface of selected mouse tumors.
Opolski A; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1986; 34(1):7-17. PubMed ID: 3778116
[TBL] [Abstract][Full Text] [Related]
28. H-2-restricted cytolysis of L cells doubly transformed with a cloned H-2Kb gene and cloned retroviral DNA.
Abastado JP; Plata F; Morello D; Daniel-Vedele F; Kourilsky P
J Immunol; 1985 Nov; 135(5):3512-9. PubMed ID: 3930607
[TBL] [Abstract][Full Text] [Related]
29. Induction of specific anti-tumour immunity by interferon-gamma gene-transferred murine bladder carcinoma MBT-2.
Hiura M; Hashimura T; Watanabe Y; Kuribayashi K; Yoshida O
Folia Biol (Praha); 1994; 40(1-2):49-61. PubMed ID: 7958064
[TBL] [Abstract][Full Text] [Related]
30. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
Kim M; Duty L; Herberman R; Gorelik E
Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
[TBL] [Abstract][Full Text] [Related]
31. MHC-unrestricted T-cell cytotoxicity against tumour cells.
Sponaas AM; Loveland B; Simpson E
Immunology; 1988 Feb; 63(2):233-9. PubMed ID: 3258274
[TBL] [Abstract][Full Text] [Related]
32. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
33. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
34. Further molecular and functional evidence for the expression of H-2 allodeterminants on the AKR leukemia, K36.
Festenstein H; Alonzo AD; Ferluga J; Ma BL; Santamaria M; Marelli O; Schmidt W; Flavell RA
Transplant Proc; 1983 Dec; 15(4):2107-10. PubMed ID: 6200978
[No Abstract] [Full Text] [Related]
35. Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells.
Silverman T; Rein A; Orrison B; Langloss J; Bratthauer G; Miyazaki J; Ozato K
J Immunol; 1988 Jun; 140(12):4378-87. PubMed ID: 2453581
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
37. Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells.
Meazza R; Comes A; Orengo AM; Ferrini S; Accolla RS
Eur J Immunol; 2003 May; 33(5):1183-92. PubMed ID: 12731043
[TBL] [Abstract][Full Text] [Related]
38. Novel regulation of an MHC class I gene response to interferon-gamma.
Schwarz DA; Buhlmann JE; Kuhne MR; Lam TM; White HD; Green WR
Cell Immunol; 1993 Aug; 150(1):90-100. PubMed ID: 7688271
[TBL] [Abstract][Full Text] [Related]
39. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Gorelik E; Jay G; Kwiatkowski B; Herberman RB
J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
[TBL] [Abstract][Full Text] [Related]
40. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR.
Schmidt W; Festenstein H
J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]